Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Duration of challenge immunity to coronavirus JHM in mice.

Identifieur interne : 000745 ( PubMed/Corpus ); précédent : 000744; suivant : 000746

Duration of challenge immunity to coronavirus JHM in mice.

Auteurs : S W Barthold ; A L Smith

Source :

RBID : pubmed:2554852

English descriptors

Abstract

The duration of challenge resistance in mice immunized with mouse hepatitis virus (MHV) strain JHM was examined as a model of immunity to corona-virus infection. Genetically susceptible BALB/cByJ mice were immunized by intranasal (i.n.) or per os (p.o.) inoculation with MHV-JHM or sterile tissue culture fluid (sham) then challenged i.n. with MHV-JHM or sterile tissue culture fluid 1, 6, or 12 months later. Four days after challenge, virus in nasal turbinates and liver was quantified, and prevalence of microscopic lesions in liver and gut-associated lymphoid tissue was tabulated as indices of challenge resistance. MHV-immunized and challenged groups were compared to sham-immunized and challenged groups. Mice immunized by i.n. inoculation were strongly resistant to challenge at 1, 6, and 12 months. Mice immunized by p.o. inoculation were resistant at 1 month, but became partially susceptible to reinfection at 6 and 12 months, based upon all indices. These data indicate that, depending upon route of immunization, mice can become susceptible to reinfection with the same coronavirus strain over time.

DOI: 10.1007/bf01317914
PubMed: 2554852

Links to Exploration step

pubmed:2554852

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Duration of challenge immunity to coronavirus JHM in mice.</title>
<author>
<name sortKey="Barthold, S W" sort="Barthold, S W" uniqKey="Barthold S" first="S W" last="Barthold">S W Barthold</name>
<affiliation>
<nlm:affiliation>Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Smith, A L" sort="Smith, A L" uniqKey="Smith A" first="A L" last="Smith">A L Smith</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1989">1989</date>
<idno type="RBID">pubmed:2554852</idno>
<idno type="pmid">2554852</idno>
<idno type="doi">10.1007/bf01317914</idno>
<idno type="wicri:Area/PubMed/Corpus">000745</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000745</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Duration of challenge immunity to coronavirus JHM in mice.</title>
<author>
<name sortKey="Barthold, S W" sort="Barthold, S W" uniqKey="Barthold S" first="S W" last="Barthold">S W Barthold</name>
<affiliation>
<nlm:affiliation>Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Smith, A L" sort="Smith, A L" uniqKey="Smith A" first="A L" last="Smith">A L Smith</name>
</author>
</analytic>
<series>
<title level="j">Archives of virology</title>
<idno type="ISSN">0304-8608</idno>
<imprint>
<date when="1989" type="published">1989</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antibodies, Viral (analysis)</term>
<term>Immunity</term>
<term>Intestines (immunology)</term>
<term>Intestines (pathology)</term>
<term>Liver (microbiology)</term>
<term>Liver (pathology)</term>
<term>Lymphoid Tissue (pathology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Murine hepatitis virus (immunology)</term>
<term>Murine hepatitis virus (isolation & purification)</term>
<term>Nasal Bone (microbiology)</term>
<term>Random Allocation</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Intestines</term>
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Liver</term>
<term>Nasal Bone</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Intestines</term>
<term>Liver</term>
<term>Lymphoid Tissue</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Immunity</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Random Allocation</term>
<term>Time Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The duration of challenge resistance in mice immunized with mouse hepatitis virus (MHV) strain JHM was examined as a model of immunity to corona-virus infection. Genetically susceptible BALB/cByJ mice were immunized by intranasal (i.n.) or per os (p.o.) inoculation with MHV-JHM or sterile tissue culture fluid (sham) then challenged i.n. with MHV-JHM or sterile tissue culture fluid 1, 6, or 12 months later. Four days after challenge, virus in nasal turbinates and liver was quantified, and prevalence of microscopic lesions in liver and gut-associated lymphoid tissue was tabulated as indices of challenge resistance. MHV-immunized and challenged groups were compared to sham-immunized and challenged groups. Mice immunized by i.n. inoculation were strongly resistant to challenge at 1, 6, and 12 months. Mice immunized by p.o. inoculation were resistant at 1 month, but became partially susceptible to reinfection at 6 and 12 months, based upon all indices. These data indicate that, depending upon route of immunization, mice can become susceptible to reinfection with the same coronavirus strain over time.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">2554852</PMID>
<DateCompleted>
<Year>1989</Year>
<Month>12</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>08</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0304-8608</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>107</Volume>
<Issue>3-4</Issue>
<PubDate>
<Year>1989</Year>
</PubDate>
</JournalIssue>
<Title>Archives of virology</Title>
<ISOAbbreviation>Arch. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Duration of challenge immunity to coronavirus JHM in mice.</ArticleTitle>
<Pagination>
<MedlinePgn>171-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The duration of challenge resistance in mice immunized with mouse hepatitis virus (MHV) strain JHM was examined as a model of immunity to corona-virus infection. Genetically susceptible BALB/cByJ mice were immunized by intranasal (i.n.) or per os (p.o.) inoculation with MHV-JHM or sterile tissue culture fluid (sham) then challenged i.n. with MHV-JHM or sterile tissue culture fluid 1, 6, or 12 months later. Four days after challenge, virus in nasal turbinates and liver was quantified, and prevalence of microscopic lesions in liver and gut-associated lymphoid tissue was tabulated as indices of challenge resistance. MHV-immunized and challenged groups were compared to sham-immunized and challenged groups. Mice immunized by i.n. inoculation were strongly resistant to challenge at 1, 6, and 12 months. Mice immunized by p.o. inoculation were resistant at 1 month, but became partially susceptible to reinfection at 6 and 12 months, based upon all indices. These data indicate that, depending upon route of immunization, mice can become susceptible to reinfection with the same coronavirus strain over time.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Barthold</LastName>
<ForeName>S W</ForeName>
<Initials>SW</Initials>
<AffiliationInfo>
<Affiliation>Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>A L</ForeName>
<Initials>AL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>RR02039</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Austria</Country>
<MedlineTA>Arch Virol</MedlineTA>
<NlmUniqueID>7506870</NlmUniqueID>
<ISSNLinking>0304-8608</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007422" MajorTopicYN="N">Intestines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008221" MajorTopicYN="N">Lymphoid Tissue</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006517" MajorTopicYN="N">Murine hepatitis virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009295" MajorTopicYN="N">Nasal Bone</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1989</Year>
<Month>1</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1989</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1989</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">2554852</ArticleId>
<ArticleId IdType="doi">10.1007/bf01317914</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Curr Top Microbiol Immunol. 1982;99:165-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6178564</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 1989;104(3-4):187-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2468325</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 1986 Nov;14(3-4):335-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3025244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 1987 May;7(3):225-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3037819</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 1986;91(3-4):247-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3022679</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lab Anim Sci. 1983 Apr;33(2):157-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6304421</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Neuropathol. 1988;76(5):502-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2847476</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000745 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000745 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:2554852
   |texte=   Duration of challenge immunity to coronavirus JHM in mice.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:2554852" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021